AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glyquit-M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Kamcure Biotech

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glyquit-M1 Tablet PR

DiabetaComb PR tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. DiabetaComb PR should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continue this treatment even if you feel well or your blood sugar is controlled; abrupt cessation without medical consultation can elevate blood sugar, risking kidney complications, vision loss, neuropathy, and limb amputation. Remember, it's one element of a comprehensive plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with its symptoms – sweating, dizziness, headache, trembling – and appropriate countermeasures. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks, juice) are crucial. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Avoid DiabetaComb PR if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your doctor of any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose checks and potentially blood tests (blood counts, liver function) will be necessary as directed by your doctor.

Primary Ingredients of Glyquit-M1 Tablet PR

The provided text is "undefined". Therefore, no rephrasing is possible.

Uses of Glyquit-M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glyquit-M1 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidance. Administer Glyquit-M1 Tablet PR with food.

Common Side effects of Glyquit-M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glyquit-M1 Tablet PR:

Follow your physician's guidance or consult the product information for dosage instructions. Administer Glyquit-M1 Tablet PR with a meal.

How Glyquit-M1 Tablet PR works:

Glyquit-M1 PR tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness in tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glyquit-M1 Tablet PR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glyquit-M1 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glyquit-M1 Tablet PR are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glyquit-M1 Tablet PR cautiously, potentially requiring dose modification. Severe kidney disease contraindicates Glyquit-M1 Tablet PR use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glyquit-M1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate hepatic dysfunction, Glyquit-M1 Tablet PR initiation typically involves a reduced starting dose; however, its use is contraindicated in patients exhibiting severe liver disease.

What if you forget to take Glyquit-M1 Tablet PR :

Should you forget a Glyquit-M1 Tablet PR dose, administer it immediately if conveniently possible. Otherwise, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glyquit-M1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glyquit-M1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glyquit-M1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glyquit-M1 Tablet PR and seek immediate medical attention.
Glyquit-M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride boosts insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glyquit-M1 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glyquit-M1 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Glyquit-M1 Tablet PR can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glyquit-M1 Tablet PR and alcohol is unsafe. This combination can dangerously lower blood sugar, causing hypoglycemia, and raise the risk of lactic acidosis.
Glyquit-M1 Tablet PR
66
MRP 80
17% off